LANZA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 13.583
AS - Asia 7.768
EU - Europa 6.058
SA - Sud America 1.226
AF - Africa 180
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.840
Nazione #
US - Stati Uniti d'America 13.257
SG - Singapore 2.921
IT - Italia 2.153
CN - Cina 1.855
BR - Brasile 978
DE - Germania 828
VN - Vietnam 813
HK - Hong Kong 626
UA - Ucraina 505
PL - Polonia 489
GB - Regno Unito 420
FR - Francia 418
TR - Turchia 405
FI - Finlandia 394
BD - Bangladesh 302
IN - India 204
RU - Federazione Russa 202
SE - Svezia 195
JP - Giappone 185
CA - Canada 150
NL - Olanda 131
MX - Messico 121
ID - Indonesia 115
AR - Argentina 92
ZA - Sudafrica 67
ES - Italia 59
IQ - Iraq 54
AT - Austria 53
BE - Belgio 44
PK - Pakistan 43
EC - Ecuador 38
PH - Filippine 34
MA - Marocco 31
VE - Venezuela 31
SA - Arabia Saudita 27
CH - Svizzera 26
LT - Lituania 25
CO - Colombia 23
UZ - Uzbekistan 22
MY - Malesia 20
AE - Emirati Arabi Uniti 19
AU - Australia 19
CL - Cile 19
CZ - Repubblica Ceca 19
EG - Egitto 18
PY - Paraguay 17
TN - Tunisia 17
RO - Romania 16
BG - Bulgaria 15
JM - Giamaica 14
JO - Giordania 14
UY - Uruguay 12
IE - Irlanda 11
KR - Corea 11
KE - Kenya 10
KZ - Kazakistan 10
AZ - Azerbaigian 9
DZ - Algeria 9
IR - Iran 9
TH - Thailandia 9
AL - Albania 8
IL - Israele 8
KG - Kirghizistan 8
PE - Perù 8
DK - Danimarca 7
DO - Repubblica Dominicana 7
GR - Grecia 7
HN - Honduras 7
OM - Oman 7
BO - Bolivia 6
NP - Nepal 6
RS - Serbia 6
CR - Costa Rica 5
ET - Etiopia 5
HU - Ungheria 5
NI - Nicaragua 5
SN - Senegal 5
GT - Guatemala 4
LB - Libano 4
PT - Portogallo 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
BH - Bahrain 3
CI - Costa d'Avorio 3
GH - Ghana 3
HR - Croazia 3
KH - Cambogia 3
NO - Norvegia 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BY - Bielorussia 2
EU - Europa 2
LU - Lussemburgo 2
MM - Myanmar 2
MN - Mongolia 2
PR - Porto Rico 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 28.808
Città #
Singapore 1.797
Ashburn 1.596
Woodbridge 1.011
Fairfield 1.003
San Jose 948
Chandler 627
Santa Clara 620
Hong Kong 611
Beijing 575
Jacksonville 563
Houston 561
Ann Arbor 526
Warsaw 474
Seattle 387
Wilmington 341
New York 323
Cambridge 298
Ferrara 288
Los Angeles 248
Ho Chi Minh City 242
Izmir 229
Munich 222
Dallas 211
Nanjing 193
Helsinki 183
Milan 182
Hanoi 181
Tokyo 176
Dearborn 164
Princeton 153
Rome 139
Lauterbourg 126
Council Bluffs 121
Boardman 107
San Diego 104
São Paulo 100
Shanghai 96
Bologna 94
Orem 90
Turku 88
Jakarta 83
Chicago 74
Mexico City 71
London 68
Buffalo 66
Nanchang 66
Hefei 64
Shenyang 58
The Dalles 58
Denver 57
Frankfurt am Main 56
Amsterdam 51
Nuremberg 49
Tianjin 48
Montreal 44
Palermo 44
Atlanta 43
Chennai 43
Phoenix 43
Da Nang 42
Naples 42
Poplar 41
Stockholm 41
Toronto 41
Brooklyn 40
Brussels 37
San Francisco 37
Johannesburg 36
Boston 34
Manchester 34
Kunming 33
Changsha 32
Moscow 32
Redwood City 32
Bremen 31
Rio de Janeiro 31
Jinan 29
Ankara 28
Catania 28
Hebei 28
Jiaxing 27
Dong Ket 26
Florence 26
Guangzhou 26
Haiphong 26
Mumbai 26
Columbus 25
Falkenstein 25
Addison 23
Norwalk 23
Falls Church 22
San Mateo 22
Belo Horizonte 21
Washington 21
Dhaka 20
Ningbo 20
Orange 20
Paris 20
Brasília 19
Hải Dương 19
Totale 18.270
Nome #
Adenoma-carcinoma del retto-colon. Linee guida e criteri diagnostici minimi. 1.283
Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs including anti-TNF 447
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 361
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 360
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 306
Perdita di espressione delle proteine MLH1, MSH2, MSH6 ed instabilità dei microsatelliti nel carcinoma dell'endometrio 287
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 284
PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development 278
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 278
Gastrointestinal stromal tumors and other malignancies: A case series 274
A New Case of Syringocystadenocarcinoma Papilliferum: A Rare Pathology for a Wide-Ranging Comprehension 271
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2 269
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 260
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 258
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 258
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 258
Histologic and sonographic features of holmium laser in the treatment of chronic venous disease 253
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 248
Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability - Response 247
MicroRNA involvement in hepatocellular carcinoma 236
Amelanotic metastasing melanoma mimicking lung cancer 236
Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients 235
MIR-501 DEPLETION INDUCES CELL CYCLE INHIBITION BY MTOR AND P53 MODULATION IN RENAL CARCINOMA 234
An apparently untreatable ulcer of the face 233
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 232
Feasibility of sentinel lymph node (sln) biopsy in colic cancer 229
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 229
Loss of cortical GABA terminals in Unverricht–Lundborg disease 227
Fhit protein expression in human gastric cancer and related precancerous lesions 226
Assessment of MLH1 promoter methylation and BRAF gene mutation in colorectal carcinomas with microsatellite instability 224
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 220
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 217
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 216
Colorectal tumors: The histology report 215
Role of MGMT methylation status at time of diagnosis and recurrence for patients with glioblastoma: clinical implications 212
MiR501-5p stimulating the activity of mToR may result a risk factor for a poor prognosis of clear cell kidney carcinoma 211
The role of immunohistochemistry in the identification of BRAF V600E mutated colorectal cancer 209
Clinical and technical validation of a genomic classifier (ColoPrint) for predicting outcome of patients with stage II colon cancer. 207
Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization 206
Medullary-type poorly differentiated adenocarcinoma of the large bowel: A distinct clinicopathologic entity characterized by microsatellite instability and improved survival 201
Analysis of BRAF Gene Mutation and MLH1 Promoter Methylation in MSI-H Colorectal Carcinomas with Loss of MLH1 Protein Expression 201
Biologic characterization of hereditary non-polyposis colorectal cancer: Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters 197
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 197
Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood 196
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 195
Pathologic and molecular features of BRAF mutated colorectal adenocarcinomas 195
Genomic classifier coloprint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors 195
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer 193
MGMT expression in colorectal cancer: relation to clinicopathologic and molecular features 192
Feasibility of sentinel lymph node (sln) byopsy in colic cancer 192
Frequent aberrant methylation of the CDH4 gene-promoter in human colorectal and gastric cancer 192
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 192
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 191
Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. 191
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 190
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 190
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 188
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells 187
Ependymomas, Malignant Tumors of Pancreatic Islets, and Osteosarcomas Induced in Hamsters by BK Virus, a Human Papovavirus 187
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 187
SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer 184
The prognostic role of gender and MGMT methylation status in glioblastoma patients: The female power 183
Hsa-microRNA-1249-3p/Homeobox A13 axis modulates the expression of β-catenin gene in human epithelial cells 179
Segmented filamentous bacteria-like organisms in histological slides of ileo-cecal valves in patients with ulcerative colitis 179
The first two years of colorectal cancer screening in Ferrara, Italy 179
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy 177
Modulation of mismatch repair and genomic stability by miR-155 172
Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection 171
Colorectal cancer screening in Ferrara: Results in early (2005-2009) and late (2009-2013) screening periods and surgical treatment of the screenees versus pre-screening (2003-2005) unselected population. 171
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 170
Oncogenic role of miR-483-3p at the IGF2/483 locus 170
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 169
A microRNA expression signature of human solid tumors defines cancer gene targets 168
Detection of disease-causing mutations in prostate cancer by NGS sequencing 168
p53 Expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern, and short-term survival 167
Anti-miR-135b in colon cancer treatment 167
Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of Radiomics 166
Epigenetic Regulation: A Link between Inflammation and Carcinogenesis 165
Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal 163
PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironment 162
Espressione del gene MGMT nel carcinoma colo-rettale: correlazioni cliniche, patologiche e biomolecolari 161
Third Round of Colorectal Cancer Screening in Ferrara (2009-2011): Prevalence of Colorectal Cancer and Advanced Adenoma and Comparison with a 2-year Prescreening Period (2003-2005) 159
Microsatellite instability in multiple colorectal tumors 158
MicroRNA501 may affect the aggressiveness of clear cell renal carcinoma 158
Identification and classification of Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the Study of Hereditary Colorectal Tumors Consensus Group 157
p53 protein expression in the colorectal adenoma-carcinoma sequence 157
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 155
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 154
Sensitive and specific detection of lung cancer DNA in bronchial washing by a novel methylation-specific droplet digital PCR 152
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 150
Valutazione di parametri prognostici nel carcinoma del colon-retto. II. Ploidia mediante citometria a flusso. 150
Late-onset intrauterine growth restriction and HHV-6 infection: A pilot study 150
Instabilità dei microsatelliti ed espressione delle proteine del mismatch repair nel carcinoma endometriale 150
Methylenetetrahydrofolate reductase 677 C -> T polymorphism and risk of proximal colon cancer in North Italy 145
Preoperative endoscopic tattooing to mark the tumour site does not improve lymph node retrieval in colorectal cancer: A retrospective cohort study 143
Targeted Sequencing Approach For Prostate Cancer Using Ion Torrent Personal Genome Machine (PGM ™) Platform 141
P3.03-22 IL-1β as a New Early Predictive Biomarker for Non-Small Cell Lung Cancers Outcome 141
Screening patologico per la identificazione dei tumori colo-rettali con deficit del DNA mismatch repair 140
Nothing but lung and bones: Longitudinal evolution and quantitative analysis in a case of idiopathic diffuse pulmonary ossification 140
Cost-effectiveness of colonoscopy colorectal cancer (CRC) screening in asymptomatic increased risk subjects 139
Totale 21.413
Categoria #
all - tutte 121.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 0 0 0 0 0 0 0 0 0 183
2021/20221.558 79 177 109 64 79 75 67 107 57 139 123 482
2022/20231.663 171 111 73 199 217 200 90 157 207 40 113 85
2023/20241.273 101 135 77 44 107 203 84 104 44 55 66 253
2024/20254.416 128 122 327 229 441 427 256 238 718 421 671 438
2025/202611.732 1.089 469 866 1.324 1.597 828 1.448 644 1.141 1.242 686 398
Totale 29.168